Table 9 Reported adverse events
Response | Robenacoxib (s.c. + oral) | Meloxicam s.c. + oral placebo | P value (Fisher exact test) |
|---|---|---|---|
Abdominal cavity hernia | 0/101 (0%) | 1/46 (2%) | 0.31 |
Anorexia | 1/101 (1%) | 0/46 (0%) | 1.0 |
Blood in faeces | 1/101 (1%) | 1/46 (2%) | 1.0 |
Diarrhoea | 7/101 (7%) | 3/46 (7%) | 1.0 |
Disorientation | 1/101 (1%) | 0/46 (0%) | 1.0 |
Emesis | 13/101 (13%) | 5/46 (11%) | 0.79 |
Eye redness | 1/101 (1%) | 0/46 (0%) | 1.0 |
Loose stool | 9/101 (9%) | 4/46 (9%) | 1.0 |
Muscle tremor | 1/101 (1%) | 0/46 (0%) | 1.0 |
Pain not otherwise specified | 0/101 (0%) | 1/46 (2%) | 0.31 |
Polydipsia | 0/101 (0%) | 1/46 (2%) | 0.31 |
Prostration | 1/101 (1%) | 0/46 (0%) | 1.0 |
Prolonged recovery | 1/101 (1%) | 0/46 (0%) | 1.0 |
Sneezing | 1/101 (1%) | 0/46 (0%) | 1.0 |
Spasm | 0/101 (0%) | 1/46 (2%) | 0.31 |
Vocalisation | 0/101 (0%) | 1/46 (2%) | 0.31 |
Uncoded sign | 2/101 (2%) | 1/46 (2%) | 1.0 |
Any adverse event | 30/101 (30%) | 12/46 (26%) | 0.70 |